Metrika

  • citati u SCIndeksu: [1]
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:2
  • preuzimanja u poslednjih 30 dana:2

Sadržaj

članak: 8 od 41  
Back povratak na rezultate
2016, vol. 73, br. 4, str. 376-381
Sekundarni hiperparatireoidizam u hroničnoj bolesti bubrega - etiopatogeneza, dijagnostika i lečenje
aKlinički centar Kragujevac, Klinika za urologiju, nefrologiju i dijalizu + Univerzitet u Kragujevcu, Fakultet medicinskih nauka
bUniverzitet u Kragujevcu, Fakultet medicinskih nauka

e-adresamileta.poskurica@gmail.com
Projekat:
Analiza strukture troškova i uticaja na zdravstveni budžet Republike Srbije epidemiološki najmasovnijih i/ili najskupljih oboljenja i procena odnosa troškovi / efektivnost / korisnost medicinskih intervencija (MPNTR - 175014)

Sažetak
Članak ne sadrži sažetak.
Reference
Applbaum, Y.H. (2010) Imaging of the skeleton and the joints in CKD. u: The Spectrum of Mineral and Bone Disorders in Chronic Kidney Disease, Oxford: University Press, str. 199-216
Argiles, A. (1998) How do we have to use the calcium in the dialysate to optimize the management of secondary hyperparathyroidism?. Nephrology Dialysis Transplantation, 13(90003): 62-64
Canadillas, S. (2005) Calcium-Sensing Receptor Expression and Parathyroid Hormone Secretion in Hyperplastic Parathyroid Glands from Humans. Journal of the American Society of Nephrology, 16(7): 2190-2197
Cunningham, J., Lewin, E., Silver, J. (2010) Medical therapy in chronic kidney disease. u: The Spectrum of Mineral and Bone Disorders in Chronic Kidney Disease, Oxford: University Press, str. 463-483
Deykin, D., Balko, C., Bricker, N.S. (1972) On the Pathogenesis of the Uremic State. New England Journal of Medicine, 286(20): 1093-1099
Disease, K. (2009) Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl, S1-130; (113)
Gonzaley, A.E., Martin, J.K. (2010) Growth factors and cytokines in renal bone disease. u: Olgaard K., Salusky B.I., Silver J. [ur.] The spectrum of Mineral and Bone Disorders in Chronic Kidney Disease, Oxford University Press, 2nd ed, p. 137-44
Haese, D.P.C., Spasovski, G.B., Sikole, A., Hutchison, A., Freemont, T.J., Sulkova, S., Swanepoel, C., Pejanović, S., Đukanović, L., Balducci, A. (2003) A multicenter study on the effects of lanthanum carbonate (Fosrenol (TM)) and calcium carbonate on renal bone disease in dialysis patients. Kidney International, 63: S73-S78
Koizumi, M., Komaba, H., Fukagawa, M. (2013) Parathyroid Function in Chronic Kidney Disease: Role of FGF23-Klotho Axis. u: Razzaque MS [ur.] Phosphate and Vitamin D in Chronic Kidney Disease, Basel: Karger, str. 110-123
Levey, A.S., de Jong, P.E., Coresh, J., Nahas, M.E.l., Astor, B.C., Matsushita, K., Gansevoort, R.T., Kasiske, B.L., Eckardt, K. (2011) The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney International, 80(1): 17-28
Levy, J., Morgan, J., Brown, E. (2007) Complications of ESRD: Renal bone disease. u: Levy J., Morgan J., Brown E. [ur.] Oxford handbook of dialysis, New York: Oxford University Press, 2nd ed, p. 653-82
Lewin, E., Rodriguez, M. (2010) Abnormal parathyroid gland function in CKD. u: The Spectrum of Mineral and Bone Disorders in Chronic Kidney Disease, Oxford: University Press, str. 77-107
Lewin, E., Garfia, B., Almaden, Y., Rodriguez, M., Olgaard, K. (2003) Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats. Kidney International, 64(1): 63-70
National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis, 42(4 Suppl 3): S1-201
Naveh-Many, T., Silver, J. (2010) Regulation of parathyroid hormone biosynthesis and gene expression. u: The Spectrum of Mineral and Bone Disorders in Chronic Kidney Disease, Oxford: University Press, str. 61-75
Nemeth, E.F. (2010) Calcimimetics and calcilytics in the treatment of chronic kidney disease-mineral and bone disorder. u: The Spectrum of Mineral and Bone Disorders in Chronic Kidney Disease, Oxford: University Press, str. 443-461
Ogata, H., Koiwa, F., Shishido, K., Takahashi, K., Ito, H., Kinugasa, E., Taguchi, S. (2007) Effects of 22-Oxacalcitriol and Calcitriol on PTH Secretion and Bone Mineral Metabolism in a Crossover Trial in Hemodialysis Patients With Secondary Hyperparathyroidism. Therapeutic Apheresis and Dialysis, 11(3): 202-209
Ott, M.S. (2010) New aspects of normal bone biology. u: Olgaard K., Salusky B.I., Silver J. [ur.] The spectrum of Mineral and Bone Disorders in Chronic Kidney Disease, Oxford University Press, 2nd ed, p. 15-30
Park, J., Rhee, C., Lau, W., Kalantar-Zadeh, K. (2014) Clinical Uses of 1-Alpha-Hydroxy-Ergocalciferol. Current Vascular Pharmacology, 12(2): 306-312
Petrović, D., Stojimirović, B. (2010) Secondary hyperparathyroidism: Risk factor for development of cardiovascular complications in patients on hemodialysis. Medicinski pregled, vol. 63, br. 9-10, str. 674-680
Petrović, D., Obrenović, R., Trbojević-Stanković, J., Majkić-Singh, N., Stojimirović, B. (2012) Hyperphosphatemia: The risk factor for adverse outcome in maintenance hemodialysis patients. Journal of Medical Biochemistry, vol. 31, br. 3, str. 239-245
Poskurica, M., Lazarević, M., Petrović, D., Lazarević, T., Milošević, J. (1999) Calcium and phosphate disturbances and its regulating hormones in chronic renal failure. u: XXXVI Congress of EDTA- ERA, EDTA-ERA, Spain, Madrid, September 5-8, Abstract 38
Poskurica, M. (1989) Dynamics of fractional phosphate excretion in chronic renal failure. Belgrade: University of Belgrade, School of Medicine, thesis
Poskurica, M. (2003) Renal osteodystrophy in patients on peritoneal dialysis. u: Nesić V. [ur.] Peritoneal dialysis: A clinical problem, Belgrade: Faculty of Medicine, p. 167-95, (Serbian, English)
Poskurica, M. (1993) Imbalance of phosphate, calcium and magnesium ions in development of chronic renal failure. Belgrade: University of Belgrade-School of Medicine, [dissertation], (Serbian)
Poskurica, M., Lazarevic, M., Grubor, M., Lakovic, S., Mitrovic, N., Milosevic, J. (1999) Metastatic calcification of the heart in patients with terminal renal failure. Medicinska istraživanja, 13(2); 109-13
Poskurica, M. (2004) The importance of vitamin D in preventing progression and complications of terminal renal failure. u: Stolic R. [ur.] Preventive Nephrology, Leskovac: School of dialysis, p. 229-36, (Serbian)
Ritter, C.S., Armbrecht, H.J., Slatopolsky, E., Brown, A.J. (2006) 25-Hydroxyvitamin D3 suppresses PTH synthesis and secretion by bovine parathyroid cells. Kidney International, 70(4): 654-659
Sarfati, E., Drueke, B.T. (2010) Surgical management of secondary hyperparathroidism. u: Olgaard K., Salusky B.I., Silver J. [ur.] The spectrum of Mineral and Bone Disorders in Chronic Kidney Disease, Oxford University Press, 2nd ed, p. 543-59
Ureña, P., Olgaard, K., Martin, K. (2010) Biochemical markers of bone metabolism in CKD. u: The Spectrum of Mineral and Bone Disorders in Chronic Kidney Disease, Oxford: University Press, str. 173-198
 

O članku

jezik rada: engleski
vrsta rada: prilog
DOI: 10.2298/vsp141218024P
objavljen u SCIndeksu: 06.04.2016.
Creative Commons License 4.0